Zepp Health Corporation Sponsored ADR (NYSE:ZEPP – Get Free Report)’s share price fell 6.9% on Thursday . The company traded as low as $44.22 and last traded at $45.50. 112,408 shares traded hands during trading, a decline of 61% from the average session volume of 284,972 shares. The stock had previously closed at $48.88.
Analysts Set New Price Targets
A number of brokerages have weighed in on ZEPP. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zepp Health in a report on Friday. Fundamental Research set a $60.23 price target on Zepp Health and gave the stock a “buy” rating in a report on Tuesday, August 26th. Finally, Wall Street Zen upgraded Zepp Health to a “hold” rating in a report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Zepp Health presently has a consensus rating of “Hold” and an average target price of $60.23.
Read Our Latest Analysis on ZEPP
Zepp Health Stock Performance
Institutional Trading of Zepp Health
A hedge fund recently bought a new stake in Zepp Health stock. Ariose Capital Management Ltd bought a new stake in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 27,717 shares of the company’s stock, valued at approximately $1,269,000. Zepp Health accounts for 0.4% of Ariose Capital Management Ltd’s holdings, making the stock its 27th largest holding. Ariose Capital Management Ltd owned 0.19% of Zepp Health at the end of the most recent reporting period. Institutional investors own 52.61% of the company’s stock.
Zepp Health Company Profile
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Featured Stories
- Five stocks we like better than Zepp Health
- Top Stocks Investing in 5G Technology
- Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MarketBeat Week in Review – 10/20 – 10/24
- How to Buy Gold Stock and Invest in Gold
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
